Skip to main content
SpringerLink
Log in

Antikörper kann Asthma kontrollieren helfen

  • Literatur kompakt
  • Published:
Pädiatrie Aims and scope

Der monoklonale IgE-Antikörper Omalizumab ist zugelassen zur Add-on-Therapie bei Erwachsenen und Kindern ab sechs Jahren. Eine aktuelle Metaanalyse dokumentiert die Evidenz für Wirksamkeit und Sicherheit dieser Therapie, deckt aber auch offene Fragen auf.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Normansell R, Walker S, Milan SJ, Nair P. Omalizumab for asthma in adults and children (Review). The Cochrane Library 2014 Issue 1: CD003559

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Thomas Spindler

Authors
  1. Thomas Spindler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spindler, T. Antikörper kann Asthma kontrollieren helfen. Pädiatrie 26, 167 (2014). https://doi.org/10.1007/s15014-014-0373-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15014-014-0373-9

Search

Navigation